Non‐ST‐segment elevation ACS: does choice of antiplatelet therapy affect outcomes across troponin categories?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Linear relationship was observed between increasing peak troponin and 30-mo ischaemic events in patients with non‐ST‐segment elevation acute coronary syndromes (NSTEACS).
  • Prasugrel vs clopidogrel showed no significant benefit in outcomes according to peak troponin.

Why this...